Wednesday, July 23, 2014 8:14:40 PM
I can simply refer you to Hypersolar website basic info. which is legit, and to Edvadaily website to get insight from an investors point of view non-bias. Not much to discern re HYSR and does not intend to be like "PLUG" or it's peers/competitors. Unfortunately, many wishful thinking people wanting this to be like "PLUG", not! Different model and different agenda. HYSR is readily preparing to demonstrate to the industry it's technology which is separate from the rest.
PRO's in no particular order:
1. R&D company
2. CEO with an impressive Accolade resume' and in partnership with UCSB.
3. Meeting projected goals within it's technology.
4. Does not generate revenue and does not sell product, and agree is burning cash, but it is the cost of any R&D.
5. Filing it's unique patents.
6. Exposing it's technology with prominent science publishers.
7. Does not retain/expose itself with pump and dump analysts.
8. In the process to reaching it's goal of 1.23v and maybe even 1.30v (short-term). And 1.5v is it's ultimate goal and takes a dedicated group of investors to invest and capitalize when the 1.5v goal is reached.
R&D companies are a dime a dozen and is the responsibility of the investor to do your owner due diligence.
Recent HYSR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:13:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM